|2004N-0133 - Part 11 Public Meeting; June 11, 2004|
|FDA Comment Number :||EC22|
|Submitter :||Dr. Madeleine Kennedy||Date & Time:||09/07/2004 08:09:24|
|Organization :||Eli Lilly and Company|
| Eli Lilly and Company appreciates the opportunity to provide comments on Docket No. 2004N-0133. Attached are our comments.
Madeleine Kennedy, Ph.D.
Director Computer Systems Quality Assurance
Global Quality System Manager - Computer Systems